4//SEC Filing
Schott Robert J. 4
Accession 0001209191-22-014176
CIK 0001001233other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:20 PM ET
Size
8.3 KB
Accession
0001209191-22-014176
Insider Transaction Report
Form 4
Schott Robert J.
SVP, Head of Development
Transactions
- Award
Common Stock
2022-02-25+41,000→ 75,537 total - Award
Stock Option (Right to Buy)
2022-02-25+110,700→ 110,700 totalExercise: $5.90Exp: 2032-02-24→ Common Stock (110,700 underlying)
Footnotes (3)
- [F1]Represents shares of common stock issuable upon settlement of a restricted stock unit ("RSU") grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.
- [F2]Includes 26,668 shares subject to the Reporting Person's February 12, 2021 RSU grant that will vest in two remaining annual installments of 13,332 shares and 13,336 shares on February 12, 2023 and 2024, respectively, subject to Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.
- [F3]One-quarter (1/4) of the shares subject to the option will vest and become exercisable on the first anniversary of the grant date, and the remainder of the shares will vest and become exercisable in 24 successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.
Documents
Issuer
SANGAMO THERAPEUTICS, INC
CIK 0001001233
Entity typeother
Related Parties
1- filerCIK 0001845310
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 5:20 PM ET
- Size
- 8.3 KB